BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 920738)

  • 21. Diagnosis and management of acute bronchitis.
    Knutson D; Braun C
    Am Fam Physician; 2002 May; 65(10):2039-44. PubMed ID: 12046770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Our clinical experience with a new antitussive secretolytic drug].
    Cuocolo R; Jovino R; Tufano R; Triggiani E
    Minerva Med; 1969 Sep; 60(76):3565-70. PubMed ID: 5823751
    [No Abstract]   [Full Text] [Related]  

  • 23. [Medications for cough].
    Festen J
    Ned Tijdschr Geneeskd; 1987 Sep; 131(38):1652-5. PubMed ID: 3670459
    [No Abstract]   [Full Text] [Related]  

  • 24. [A contribution to the treatment of bronchial diseases].
    Seitz H
    Landarzt; 1966 Dec; 42(36):1636-7. PubMed ID: 5978097
    [No Abstract]   [Full Text] [Related]  

  • 25. [Antitussive agents. 34].
    Eichhorn A
    Pharm Prax; 1969; 7():148-52. PubMed ID: 4390218
    [No Abstract]   [Full Text] [Related]  

  • 26. Management of tracheobronchial secretions.
    Rodman T
    Am J Nurs; 1966 Nov; 66(11):2474-7. PubMed ID: 5178846
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparative investigation of Libexin and Hydrocodin.
    Kiss J; Pongor F; Nagy M
    Ther Hung; 1968; 16(2):79-82. PubMed ID: 5666419
    [No Abstract]   [Full Text] [Related]  

  • 28. [Analytical characteristics of antitussive drugs].
    Cavicchi GS; Cristofori B; Quaglio MP
    Boll Chim Farm; 1969 Nov; 108(11):682-9. PubMed ID: 5378690
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical experience with the drug NA-274 in the form of tablets and aerosol solution].
    Ferris Santes M; Galbis Palau JL; SaĆ­nz Bas C
    Med Esp; 1965 May; 53(314):409-14. PubMed ID: 5845908
    [No Abstract]   [Full Text] [Related]  

  • 30. [Chemico-pharmacological studies on antitussives. II. On the site of antitussive action of 1-(3',4'-dihydroxyphenacyl)-4-(2-hydroxypropyl) piperazine dihydrochloride].
    KASE Y; YUIZONO T; MASUDA M; MUTO M; MIYAMOTO S; TAGAWA Y
    Yakugaku Zasshi; 1962 Sep; 82():1298-302. PubMed ID: 14031069
    [No Abstract]   [Full Text] [Related]  

  • 31. [Antitussive, expectorant and anti-asthmatic effects of Cynanchum glaucescens (Decne.) Hand. -Mazz].
    Liang A; Xue B; Yang Q; Li Z
    Zhongguo Zhong Yao Za Zhi; 1995 Mar; 20(3):176-8, inside front cover. PubMed ID: 7646783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Bisolovone-Linctus in the treatment of bronchitis].
    Barckhausen E
    Med Monatsschr; 1966 Sep; 20(9):419-20. PubMed ID: 5975339
    [No Abstract]   [Full Text] [Related]  

  • 33. [On rational drug therapy of nonspecific bronchitic syndrome].
    Dittrich W
    Med Welt; 1967 Oct; 42():2506-8. PubMed ID: 5615284
    [No Abstract]   [Full Text] [Related]  

  • 34. Cough medicines.
    Drug Ther Bull; 1985 Nov; 23(22):85-7. PubMed ID: 4064924
    [No Abstract]   [Full Text] [Related]  

  • 35. [Principles of drug therapy: symptomatic therapy of coughing and bronchial asthma].
    Arntz HR
    Dtsch Krankenpflegez; 1974 Dec; 27(12):647-51. PubMed ID: 4497783
    [No Abstract]   [Full Text] [Related]  

  • 36. [Is preparation for common cold effective?].
    Ohta Y
    Kokyu To Junkan; 1992 Feb; 40(2):145-9. PubMed ID: 1565879
    [No Abstract]   [Full Text] [Related]  

  • 37. [The parenteral use of a derivative of benzylamine in the control of tracheobronchial patological secretions].
    Bianchetti L; Chiri A
    Minerva Med; 1969 Sep; 60(75):3521-4. PubMed ID: 5344812
    [No Abstract]   [Full Text] [Related]  

  • 38. Center offers first OTC drug/conditions chart.
    Layne BA; Seibert DJ
    Pa Med; 1998 Apr; 101(4):20. PubMed ID: 9581120
    [No Abstract]   [Full Text] [Related]  

  • 39. [Prolonged automatic respiration and bronchial obstruction. Experience with a new "expectorant" in a Resuscitation Department].
    De Medici M; Del Vecchio PE
    Minerva Med; 1969 Sep; 60(76):3571-4. PubMed ID: 5823752
    [No Abstract]   [Full Text] [Related]  

  • 40. Investigation of xyloxemine hydrochloride, 2-[2-(di-2,6-xylylmethoxy)ethoxy]-N,N-dimethylethylamine hydrochloride (BS 6748).
    Doorenbos HJ; Rekker RF; Nauta WT
    Pharm Weekbl; 1966 Jul; 101(26):565-9. PubMed ID: 5916606
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.